Shenzhen Bay Laboratory describes new compounds for aldehyde metabolism disorders
Sep. 29, 2025
Shenzhen Bay Laboratory has identified compounds reported to be useful for the treatment of cancer, eye, cardiovascular, metabolic, autoimmune, inflammatory, neurological and dermatological disorders.